Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28054954 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1HSD17B10LMNAKDM4E | |
| SCHEMBL369243 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TDP1LMNAKDM4EGMNN | |
| SCHEMBL4450989 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TDP1LMNAKDM4EGMNN | |
| SCHEMBL2020687 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TDP1LMNAKDM4EGMNN | |
| SCHEMBL11846946 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TDP1LMNAKDM4EGMNN | |
| SCHEMBL10462586 | 0.79 | ADRB2 (0.48) | ALDH1A1TDP1LMNAHPGDTSHR | |
| SCHEMBL6725173 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TDP1LMNAKDM4EGMNN | |
| SCHEMBL25518782 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TDP1LMNAKDM4EGMNN | |
| Isopropylbenzene SCHEMBL1416132 | 0.78 | ALDH1A1 (0.44) | ALDH1A1TDP1HSD17B10LMNAKDM4E | |
| SCHEMBL7343137 | 0.77 | CYP3A4 (0.40) | ALDH1A1LMNAPOLBMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105699509-B | A kind of method for separating and detecting of 3- amino butanols enantiomter | 河北科技大学 | 2018-08-31 | — | — | CN | claimed |
| CN-105510509-B | A kind of assay method of 3 amino piperidine enantiomter overrate | 河北科技大学 | 2017-06-16 | — | — | CN | claimed |
| CN-105510511-B | HPLC (High Performance Liquid Chromatography) separation and detection method of 2-aminobutanol enantiomer | 河北科技大学 | 2017-04-12 | — | — | CN | claimed |
| CN-105675782-B | 3-aminopiperdine chiral purity analysis method | 河北科技大学 | 2017-04-12 | — | — | CN | claimed |
| CN-105675782-A | 3-aminopiperdine chiral purity analysis method | 河北科技大学 | 2016-06-15 | — | — | CN | claimed |
| CN-104277000-A | Abscisic acid receptor stimulant raw drug and preparation method thereof | SHANGHAI LVANG BIOTECHNOLOGY CO LTD | 2015-01-14 | — | — | CN | claimed |
| EP-0414018-A2 | Process for the preparation of dehydrocycloclausenamide and its derivatives in the racemic form and as optically active (+)- or (-)-enantiomers | BAYER AG (DE) | 1991-02-27 | — | — | EP | claimed |
| WO-2025136811-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | IDEAYA BIOSCIENCES, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025034745-A1 | 4-AMINOPIPERIDINES AS SELECTIVE MODULATORS OF POTASSIUM CHANNELS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-02-13 | — | — | WO | disclosed |
| CN-113341054-A | Method for measuring excess rate of 1-NEA enantiomer | 河北科技大学 | 2021-09-03 | — | — | CN | disclosed |
| CN-113341053-A | Analysis method for chiral purity of 1-naphthylethylamine | 河北科技大学 | 2021-09-03 | — | — | CN | disclosed |
| CN-105699509-B | A kind of method for separating and detecting of 3- amino butanols enantiomter | 河北科技大学 | 2018-08-31 | — | — | CN | disclosed |
| CN-105699509-B | A kind of method for separating and detecting of 3- amino butanols enantiomter | 河北科技大学 | 2018-08-31 | — | — | CN | disclosed |
| US-20030144282-A1 | Inhibitors of cytosolic phospholipase A2 | WYETH | 2003-07-31 | — | — | US | disclosed |
| WO-2003048122-A2 | INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 | WYETH (US) | 2003-06-12 | — | — | WO | disclosed |
| CN-1313863-A | Inhibitors of urokinase and angiogenesis | CORVAS INTERNAT INC (US) | 2001-09-19 | — | — | CN | disclosed |
| WO-1996038552-A1 | POST-TRANSCRIPTIONAL GENE REGULATION BY SELENIUM | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1996-12-05 | — | — | WO | disclosed |
| CN-1076452-A | 3,4 '-dideoxy mycaminose base tylosin cyclic lactone derivatives and manufacture method thereof | ZAIDAN HOJIN BISEIBUTSU (JP) | 1993-09-22 | — | — | CN | disclosed |
| US-4990637-A | Chemical intermediates | BAYER AKTIENGESELLSCHAFT (DE) | 1991-02-05 | — | — | US | disclosed |
| US-4806147-A | Substituted 1-benzylsulphonyl-3-heteroaryl-(thio)urea herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144282-A1 | Inhibitors of cytosolic phospholipase A2 | PLA2G4A, PLA2G4B, PLA2G4C | ALDH1A1 1910/4885TDP1 1881/4885HSD17B10 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.